Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ann F Hoffman

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Combinatorial Chemistry & High Throughput Screening|June 18, 2009
Instrumental considerations in high content screeningChris Shumate, Ann F Hoffman
SLAS Discovery : Advancing Life Sciences R & D|September 20, 2021
Advances in High-Content Imaging and Informatics: A Joint Special Collection with Society for Biomolecular Imaging and Informatics and SLASJustin D Boyd, Ann F Hoffman
Methods in Molecular Biology (Clifton, N.J.)|September 22, 2006
A pharmaceutical company user's perspective on the potential of high content screening in drug discoveryAnn F Hoffman, Ralph J Garippa
Assay and Drug Development Technologies|January 19, 2019
Society of Biomolecular Imaging and Informatics High-Content Screening/High-Content Analysis Preclinical Translational Imaging Colloquium: How Emerging Technologies in Disease Models, High-Content Imaging, and Data Analytics Are Changing Our Approach to Drug DiscoveryJustin D Boyd, Ann F Hoffman, David Gebhard
Expert Opinion on Investigational Drugs|November 29, 2007
Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease: preclinical and clinical developmentsAlexandra Hicks, Seth P Monkarsh, Ann F Hoffman, et al.
Methods in Enzymology|November 18, 2006
High-throughput confocal microscopy for beta-arrestin-green fluorescent protein translocation G protein-coupled receptor assays using the Evotec OperaRalph J Garippa, Ann F Hoffman, Gabriele Gradl, et al.
Bioinformatics (Oxford, England)|December 14, 2011
A simple statistical test to infer the causality of target/phenotype correlation from small molecule phenotypic screensXin Wei, Ann F Hoffman, Shannon M Hamilton, et al.
Assay and Drug Development Technologies|January 19, 2018
Society of Biomolecular Imaging and Informatics High-Content Screening/High-Content Analysis Emerging Technologies in Biological Models, When and Why?Ann F Hoffman, John Nolan, David F Gebhard, et al.
Molecular Cancer Therapeutics|September 1, 2011
Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cellsDaina Z Ewton, Jing Hu, Maria Vilenchik, et al.
Assay and Drug Development Technologies|January 17, 2017
SBI<sup>2</sup> HCS/HCA 3D Imaging: Best Practices and Unmet Needs ColloquiumAnn F Hoffman, Kaylene J Simpson, Peter Horvath, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Combinatorial Chemistry & High Throughput Screening|June 18, 2009
Instrumental considerations in high content screeningChris Shumate, Ann F Hoffman
SLAS Discovery : Advancing Life Sciences R & D|September 20, 2021
Advances in High-Content Imaging and Informatics: A Joint Special Collection with Society for Biomolecular Imaging and Informatics and SLASJustin D Boyd, Ann F Hoffman
Methods in Molecular Biology (Clifton, N.J.)|September 22, 2006
A pharmaceutical company user's perspective on the potential of high content screening in drug discoveryAnn F Hoffman, Ralph J Garippa
Assay and Drug Development Technologies|January 19, 2019
Society of Biomolecular Imaging and Informatics High-Content Screening/High-Content Analysis Preclinical Translational Imaging Colloquium: How Emerging Technologies in Disease Models, High-Content Imaging, and Data Analytics Are Changing Our Approach to Drug DiscoveryJustin D Boyd, Ann F Hoffman, David Gebhard
Expert Opinion on Investigational Drugs|November 29, 2007
Leukotriene B4 receptor antagonists as therapeutics for inflammatory disease: preclinical and clinical developmentsAlexandra Hicks, Seth P Monkarsh, Ann F Hoffman, et al.
Methods in Enzymology|November 18, 2006
High-throughput confocal microscopy for beta-arrestin-green fluorescent protein translocation G protein-coupled receptor assays using the Evotec OperaRalph J Garippa, Ann F Hoffman, Gabriele Gradl, et al.
Bioinformatics (Oxford, England)|December 14, 2011
A simple statistical test to infer the causality of target/phenotype correlation from small molecule phenotypic screensXin Wei, Ann F Hoffman, Shannon M Hamilton, et al.
Assay and Drug Development Technologies|January 19, 2018
Society of Biomolecular Imaging and Informatics High-Content Screening/High-Content Analysis Emerging Technologies in Biological Models, When and Why?Ann F Hoffman, John Nolan, David F Gebhard, et al.
Molecular Cancer Therapeutics|September 1, 2011
Inactivation of mirk/dyrk1b kinase targets quiescent pancreatic cancer cellsDaina Z Ewton, Jing Hu, Maria Vilenchik, et al.
Assay and Drug Development Technologies|January 17, 2017
SBI<sup>2</sup> HCS/HCA 3D Imaging: Best Practices and Unmet Needs ColloquiumAnn F Hoffman, Kaylene J Simpson, Peter Horvath, et al.
Pageof 2